Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.
Cryptococcus neoformans releases capsular polysaccharide in the supernatant of liquid cultures and in tissues. Significantly less glucuronoxylomannan (GXM) was released by C. neoformans in the presence of capsule-binding monoclonal antibody (MAb). MAb-mediated inhibition of GXM release may be another mechanism by which humoral immunity can mediate protection against this pathogen.
Martinez
Luis R
LR
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Moussai
Dariush
D
Casadevall
Arturo
A
D000908:Antibodies, Fungal / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000276:immunology; D000946:Antigens, Fungal / Q000276:immunology* / Q000378:metabolism*; D003455:Cryptococcus neoformans / Q000254:growth & development* / Q000276:immunology / Q000378:metabolism; D003470:Culture Media; D006801:Humans; D011134:Polysaccharides / Q000276:immunology* / Q000378:metabolism
D000908:Antibodies, Fungal; D000911:Antibodies, Monoclonal; D000946:Antigens, Fungal; D003470:Culture Media; D011134:Polysaccharides; C027478:glucuronoxylomannan